Cencora (COR)
undefined
undefined%
At close: undefined
232.24
-0.06%
After-hours Dec 13, 2024, 04:10 PM EST

Company Description

Cencora, Inc. sources and distributes pharmaceutical products.

Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.

The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets.

In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics.

The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe.

This segment also provides specialty transportation and logistics services for the biopharmaceutical industry.

The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023.

Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Cencora
Cencora logo
Country United States
IPO Date Apr 4, 1995
Industry Medical - Distribution
Sector Healthcare
Employees 46,000
CEO Dr. Robert P. Mauch Ph.D., PharmD

Contact Details

Address:
1 West First Avenue
Conshohocken, Pennsylvania
United States
Website https://www.amerisourcebergen.com

Stock Details

Ticker Symbol COR
Exchange NYSE
Fiscal Year n/a
Reporting Currency USD
CIK Code 0001140859
CUSIP Number 03090BBJ8
ISIN Number US03073E1055
Employer ID 23-3079390
SIC Code 5122

Key Executives

Name Position
Dr. Robert P. Mauch Ph.D., PharmD President, Chief Executive Officer, Chief Operating Officer, Executive Vice President & Director
Elizabeth S. Campbell J.D. Executive Vice President & Chief Legal Officer
James F. Cleary Jr. Executive Vice President & Chief Financial Officer
Bennett S. Murphy Senior Vice President of Investor Relations
Jennifer E. Dubas Senior Vice President & Chief Compliance Officer
Lazarus Krikorian Senior Vice President, Chief Accounting Officer & Corporate Controller
Pawan Singh Verma Executive Vice President, Chief Data & Information Officer
Richard Tremonte EVice President & President of U.S. Pharmaceuticals
Silvana Battaglia Executive Vice President & Chief Human Resources Officer
Steven H. Collis Executive Chairman

Latest SEC Filings

Date Type Title
Dec 10, 2024 8-K Current Report
Dec 04, 2024 424B2 Filing
Dec 04, 2024 4 Filing
Dec 04, 2024 8-K Current Report
Dec 02, 2024 FWP Filing
Dec 02, 2024 4 Filing
Dec 02, 2024 424B5 Filing
Nov 27, 2024 8-K Current Report
Nov 26, 2024 4 Filing
Nov 26, 2024 S-3ASR Automatic shelf registration statement of securiti...